Sagimet Biosciences (SGMT) Shares Outstanding (Weighted Average) (2022 - 2026)

Sagimet Biosciences' Shares Outstanding (Weighted Average) history runs 5 years deep, the most recent figure standing at $32.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1.13% year-over-year to $32.6 million; the TTM figure through Mar 2026 stood at $32.6 million (up 1.13% YoY), while the FY2025 annual figure was $32.3 million, up 3.17% from the prior year.
• Shares Outstanding (Weighted Average) was $32.6 million for Q1 2026 at Sagimet Biosciences, up from $32.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $32.6 million in Q1 2026 to a low of $184589.0 in Q2 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $19.7 million across 5 years, with a median of $30.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) surged 16739.32% in 2024, then gained 0.44% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $184619.0 in 2022, then surged by 5565.9% to $10.5 million in 2023, then jumped by 199.71% to $31.4 million in 2024, then increased by 3.17% to $32.3 million in 2025, then advanced by 0.66% to $32.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $32.6 million (Q1 2026), $32.3 million (Q4 2025), and $32.3 million (Q3 2025), per Business Quant data.